Connection
Stanley Szefler to Biological Products
This is a "connection" page, showing publications Stanley Szefler has written about Biological Products.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
2.957 |
|
|
|
-
Stempel DA, Szefler SJ. Is the assessment of asthma treatment efficacy sufficiently comprehensive? J Allergy Clin Immunol. 2024 Mar; 153(3):629-636.
Score: 0.738
-
Anderson WC, Banzon TM, Chawes B, Papadopoulos NG, Phipatanakul W, Szefler SJ. Factors to Consider in Prescribing Asthma Biologic Therapies to Children. J Allergy Clin Immunol Pract. 2023 03; 11(3):693-701.
Score: 0.692
-
Stempel DA, Szefler SJ. Adding a Biologic to Asthma Therapy: The Role of Adherence in Selecting the Right Patient. J Allergy Clin Immunol Pract. 2022 11; 10(11):2949-2950.
Score: 0.682
-
Anderson WC, Szefler SJ. Cost-effectiveness and comparative effectiveness of biologic therapy for asthma: To biologic or not to biologic? Ann Allergy Asthma Immunol. 2019 04; 122(4):367-372.
Score: 0.526
-
Menzies-Gow A, Szefler SJ, Busse WW. The Relationship of Asthma Biologics to Remission for Asthma. J Allergy Clin Immunol Pract. 2021 03; 9(3):1090-1098.
Score: 0.148
-
Hoch H, Kattan M, Szefler SJ. Challenges in managing difficult-to-treat asthma in children: Stop, look, and listen. Pediatr Pulmonol. 2020 03; 55(3):791-794.
Score: 0.139
-
Lanz MJ, Gilbert I, Szefler SJ, Murphy KR. Can early intervention in pediatric asthma improve long-term outcomes? A question that needs an answer. Pediatr Pulmonol. 2019 03; 54(3):348-357.
Score: 0.033